• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24040 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2016     HAYES, Inc. Synergy bioabsorbable polymer drug-eluting stent system (Boston Scientific) for treatment of coronary artery disease
2016     Andalusian Health Technology Assessment Area (AETSA) Follow up of breast cancer in primary care. Safety and efficiency.
2016     HAYES, Inc. Talimogene laherparepvec (T-VEC; Imlygic) for treatment of unresectable melanoma lesions
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Health technology assessments on medical devices in Europe
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for the treatment of Barrett's esophagus with high-grade and lowgrade dysplasia: an update
2016     Andalusian Health Technology Assessment Area (AETSA) Orthoses indication in foot deformities in children.
2016     HAYES, Inc. Topera 3D mapping system (RhythmView Workstation and FIRMap) to guide ablation procedures for atrial fibrillation
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2016     NIHR Health Technology Assessment programme VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation
2016     HAYES, Inc. Trifluridine-tipiracil (Lonsurf) for refractory metastatic colorectal cancer
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Supply Mandates]
2016     NIHR Health Technology Assessment programme The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation
2016     NIHR Health Technology Assessment programme The use of exploratory analyses within the NICE single technology appraisal process
2016     HAYES, Inc. Ustekinumab (Stelara; Janssen Biotech Inc.) for treatment of psoriatic arthritis
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ixazomib (Ninlaro®) in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma (MM)
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) A mini-health technology assessment of Linear and Radial Endobronchial Ultrasound (EBUS) and Electromagnetic Navigation Bronchoscopy (ENB) in the diagnosis and staging of lung cancer in adults
2016     Agency for Healthcare Research and Quality (AHRQ) Management of gout
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Re-orientation of the Austrian parent-child preventive care programme. Part XII: Economic evaluation of selected screenings during pregnancy]
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Cardiac resynchronization therapy in heart failure
2016     National Institute for Health and Care Excellence (NICE) SepsiTest assay for rapidly identifying bloodstream bacteria and fungi. NICE diagnostics guidance 20
2016     NIHR Health Technology Assessment programme Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment
2016     NIHR Health Services and Delivery Research programme Developing a methodological framework for organisational case studies: a rapid review and consensus development process
2016     Agency for Healthcare Research and Quality (AHRQ) Calcineurin inhibitors for renal transplant
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of biventricular pacing in atrioventricular heart block
2016     Agency for Healthcare Research and Quality (AHRQ) Noninvasive treatments for low back pain
2016     Agency for Healthcare Research and Quality (AHRQ) Management of renal masses and localized renal cancer
2016     NIHR Health Technology Assessment programme Comparing open and minimally invasive surgical procedures for esophagectomy in the treatment of cancer: the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) feasibility study and pilot trial
2016     Agency for Healthcare Research and Quality (AHRQ) Home-based primary care interventions
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation part VII: Economic Evaluation]
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Thrombectomy for ischaemic stroke: patient characteristics, structural requirements and (differential) diagnostics]
2016     National Evidence-based Healthcare Collaborating Agency (NECA) [Development of evidence-based clinical imaging guidelines : to supply the evidence for appropriateness of diagnostic imaging studies and radiation exposure levels of patients]
2016     Health Quality Ontario (HQO) Intrathecal drug delivery systems for cancer pain: a health technology assessment
2016     Adelaide Health Technology Assessment (AHTA) Rapid sepsis detection
2016     Health Quality Ontario (HQO) Intrathecal drug delivery systems for noncancer pain: a health technology assessment
2016     NIHR Health Technology Assessment programme Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model
2016     Health Quality Ontario (HQO) Left ventricular assist devices for destination therapy: a health technology assessment
2016     Health Quality Ontario (HQO) Mechanical thrombectomy in patients with acute ischemic stroke: a health technology assessment
2016     Adelaide Health Technology Assessment (AHTA) MALDI-TOF for detection of antibiotic resistant bacteria
2016     Gesundheit Osterreich GmbH (GOeG) [Recent evidence on drug therapy of psychological and behavioral symptoms in Alzheimer's dementia]
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment- resistant depression: a systematic review and meta-analysis of randomized controlled trials
2016     Adelaide Health Technology Assessment (AHTA) Transcranial magnetic resonance-guided focused ultrasound and deep brain stimulation for refractory depression
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment-resistant depression: an economic analysis
2016     Adelaide Health Technology Assessment (AHTA) Gene expression profiling of breast cancer
2016     Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: a clinical evidence review
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vepoloxamer for vaso-occlusive crises in sickle cell disease – first line
2016     Adelaide Health Technology Assessment (AHTA) Enhanced liver fibrosis test
2016     The Swedish Council on Health Technology Assessment (SBU) [Anal sphincter injuries]
2016     Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: an economic analysis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for refractory follicular lymphoma – third line in combination with bendamustine
2016     Adelaide Health Technology Assessment (AHTA) Stenting versus medical therapy for atherosclerotic renal artery stenosis
2016     National Institute for Health and Care Excellence (NICE) High-throughput non-invasive prenatal testing for fetal RHD genotype. NICE diagnostics guidance 25
2016     The Swedish Council on Health Technology Assessment (SBU) Traumatic shaking – The role of the triad in medical investigations of suspected traumatic shaking
2016     Health Quality Ontario (HQO) Intrathecal drug delivery systems for cancer pain and noncancer pain: OHTAC recommendation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Medidur for non-infectious posterior uveitis – second line
2016     Adelaide Health Technology Assessment (AHTA) PATHFAST Presepsin chemiluminescent enzyme immunoassay for the diagnosis and prognosis of sepsis
2016     National Institute for Health and Care Excellence (NICE) ImmunoCAP ISAC 112 for multiplex allergen testing. NICE diagnostics guidance 24
2016     The Swedish Council on Health Technology Assessment (SBU) [Treatment of maternal birth injuries following vaginal birth – mapping of systematic reviews]
2016     Health Quality Ontario (HQO) Left ventricular assist devices for destination therapy: OHTAC recommendation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Epoetin alfa (Eprex) for anaemia in adults with low or intermediate-1 risk myelodysplastic syndromes
2016     Agency for Healthcare Research and Quality (AHRQ) Outcome Measures Framework: Literature review. Findings and implications. Registry of Patient Registries
2016     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Idebenone]
2016     National Institute for Health and Care Excellence (NICE) Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits). NICE diagnostics guidance 22
2016     The Swedish Council on Health Technology Assessment (SBU) [Treatment for binge eating disorder]
2016     Health Quality Ontario (HQO) Mechanical thrombectomy for patients with acute ischemic stroke: OHTAC recommendation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Naldemedine for opioid-induced constipation in adults
2016     NIHR Health Technology Assessment programme Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme
2016     The Swedish Council on Health Technology Assessment (SBU) [Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Spectrum Disorders (FASD) – conditions and interventions]
2016     Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment-resistant depression: OHTAC recommendation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pegvaliase for the treatment of hyperphenylalaninaemia in adults with phenylketonuria – first line
2016     NIHR Health Services and Delivery Research programme Towards improved decision support in the assessment and management of pain for people with dementia in hospital: a systematic meta-review and observational study
2016     Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: OHTAC recommendation
2016     NIHR Horizon Scanning Centre (NIHR HSC) KRN23 for X-linked hypophosphataemia in children aged 5-12 years – first line
2016     NIHR Health Services and Delivery Research programme Patient-level information and costing systems (PLICSs): a mixed-methods study of current practice and future potential for the NHS health economy
2016     The Swedish Council on Health Technology Assessment (SBU) [Occupational exposures and osteoarthritis]
2016     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies in autism spectrum disorder
2016     NIHR Horizon Scanning Centre (NIHR HSC) Empagliflozin (Jardiance) for preventing cardiovascular death in patients with type 2 diabetes mellitus and high cardiovascular risk
2016     NIHR Health Services and Delivery Research programme A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care
2016     NIHR Health Technology Assessment programme Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): a randomised controlled trial with cost-effectiveness analysis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Empagliflozin (Jardiance) for type 1 diabetes – adjunctive therapy
2016     NIHR Public Health Research (PHR) programme Health impacts of the Cambridgeshire Guided Busway: a natural experimental study
2016     NIHR Health Technology Assessment programme The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection
2016     NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax with rituximab for relapsed or refractory chronic lymphocytic leukaemia – second and subsequent line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pelareorep in combination with paclitaxel for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer
2016     NIHR Horizon Scanning Centre (NIHR HSC) Mogamulizumab for relapsed or refractory cutaneous T-cell lymphoma – second and subsequent lines
2016     NIHR Horizon Scanning Centre (NIHR HSC) Hexyl aminolevulinate (Cevira) for cervical high-grade squamous intraepithelial lesions
2016     NIHR Health Technology Assessment programme OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
2016     NIHR Horizon Scanning Centre (NIHR HSC) Crizotinib (Xalkori) for advanced ROS1 positive non-small cell lung cancer – first line
2016     NIHR Health Technology Assessment programme Improving outcomes for people in mental health crisis: a rapid synthesis of the evidence for available models of care
2016     NIHR Horizon Scanning Centre (NIHR HSC) Aldoxorubicin for metastatic, locally advanced or unresectable soft tissue sarcoma – second line
2016     Agency for Healthcare Research and Quality (AHRQ) Diagnosis and management of infantile hemangioma
2016     Agency for Healthcare Research and Quality (AHRQ) Resident safety practices in nursing home settings
2016     Agency for Healthcare Research and Quality (AHRQ) Contrast-induced nephropathy: comparative effects of different contrast media
2016     NIHR Public Health Research (PHR) programme Active for Life Year 5: a cluster randomised controlled trial of a primary school-based intervention to increase levels of physical activity, decrease sedentary behaviour and improve diet
2016     European Network for Health Technology Assessment (EUnetHTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2016     NIHR Health Services and Delivery Research programme The care of dying people in nursing homes and intensive care units: a qualitative mixed-methods study
2016     NIHR Health Technology Assessment programme Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review
2016     NIHR Health Technology Assessment programme Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi – a systematic review and economic evaluation
2016     Agency for Healthcare Research and Quality (AHRQ) Telehealth: mapping the evidence for patient outcomes from systematic reviews
2016     Agency for Healthcare Research and Quality (AHRQ) Newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a review
2016     NIHR Health Technology Assessment programme A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2)